Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Mulberg

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|October 29, 2008
Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDAAndrew E Mulberg
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for ChildrenAndrew E Mulberg, Timothy Cripps
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2012
US perspective on off-label use in pediatricsAlyson Karesh, Andrew E Mulberg
Pancreas|August 8, 2014
Dependence of PERT endpoint on endogenous lipase activityWen-Yi Gao, Andrew E Mulberg
Gastroenterology|August 7, 2022
ReplyLawrence Goldkind, Andrew E Mulberg, Janice Soreth
Current Opinion in Pediatrics|September 3, 2013
Off-label use of medicine in pediatrics: focus on gastrointestinal diseasesAlyson Karesh, Juli Tomaino, Andrew E Mulberg
Gastroenterology|July 10, 2022
Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet"Lawrence Goldkind, Janice M Soreth, Andrew E Mulberg
Gastroenterology|March 15, 2022
Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug DevelopmentAndrew E Mulberg, Laurie S Conklin, Nicholas M Croft, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2012
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseasesRobert Fiorentino, Gumei Liu, Anne R Pariser, et al.
Journal of Pharmaceutical Sciences|November 6, 2015
Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal DiseasesJane P F Bai, Gilbert J Burckart, Andrew E Mulberg
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Gastroenterology and Nutrition|October 29, 2008
Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDAAndrew E Mulberg
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for ChildrenAndrew E Mulberg, Timothy Cripps
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2012
US perspective on off-label use in pediatricsAlyson Karesh, Andrew E Mulberg
Pancreas|August 8, 2014
Dependence of PERT endpoint on endogenous lipase activityWen-Yi Gao, Andrew E Mulberg
Gastroenterology|August 7, 2022
ReplyLawrence Goldkind, Andrew E Mulberg, Janice Soreth
Current Opinion in Pediatrics|September 3, 2013
Off-label use of medicine in pediatrics: focus on gastrointestinal diseasesAlyson Karesh, Juli Tomaino, Andrew E Mulberg
Gastroenterology|July 10, 2022
Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet"Lawrence Goldkind, Janice M Soreth, Andrew E Mulberg
Gastroenterology|March 15, 2022
Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug DevelopmentAndrew E Mulberg, Laurie S Conklin, Nicholas M Croft, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2012
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseasesRobert Fiorentino, Gumei Liu, Anne R Pariser, et al.
Journal of Pharmaceutical Sciences|November 6, 2015
Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal DiseasesJane P F Bai, Gilbert J Burckart, Andrew E Mulberg
Pageof 5